Losartan and Ramelteon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Losartan and Ramelteon. Common interactions include cellulitis among females and on and off phenomenon among males.

The phase IV clinical study analyzes what interactions people who take Losartan and Ramelteon have. It is created by eHealthMe based on reports of 30 people who take Losartan and Ramelteon from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 11, 2022

30 people who take Losartan and Ramelteon together, and have interactions are studied.


What is Losartan?

Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 146,350 Losartan users for its effectiveness, alternative drugs and more.

What is Ramelteon?

Ramelteon has active ingredients of ramelteon. eHealthMe is studying from 1,094 Ramelteon users for its effectiveness, alternative drugs and more.

Number of Losartan and Ramelteon reports submitted per year:

Losartan and Ramelteon drug interactions.

Common Losartan and Ramelteon drug interactions by gender *:

female:

  1. Cellulitis
  2. Neutrophil count decreased
  3. Asthenia
  4. Nausea
  5. Uterine cancer
  6. Abdominal distension
  7. Adverse drug reaction
  8. Alopecia
  9. Atrial flutter
  10. Back pain

male:

  1. On and off phenomenon
  2. Device dislocation
  3. Seizure
  4. Drug clearance increased
  5. Drug level decreased
  6. Heart transplant rejection
  7. Mania
  8. Abdominal pain
  9. Alanine aminotransferase increased
  10. Asthenia

Common Losartan and Ramelteon drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug clearance increased
  2. Drug level decreased
  3. Heart transplant rejection
  4. Drug clearance decreased

30-39:

n/a

40-49:

  1. Mania
  2. Alanine aminotransferase increased
  3. Blood triglycerides increased
  4. Blood uric acid increased
  5. Presyncope
  6. Skin burning sensation

50-59:

  1. On and off phenomenon
  2. Device dislocation
  3. Freezing phenomenon
  4. Gait disturbance
  5. Hallucination
  6. Insomnia
  7. Nasopharyngitis
  8. Nephrotic syndrome
  9. Paranoia
  10. Renal vein thrombosis

60+:

  1. Cellulitis
  2. Neutrophil count decreased
  3. Balance disorder
  4. Bone pain
  5. Burning sensation
  6. Chest pain
  7. Chronic kidney disease
  8. Decreased appetite
  9. Delirium
  10. Diarrhoea

Common conditions people have *:

  1. Insomnia (sleeplessness): 8 people, 26.67%
  2. Parkinson's Disease: 5 people, 16.67%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 13.33%
  4. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 10.00%
  5. Gastritis (inflammation of stomach): 3 people, 10.00%
  6. Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 3 people, 10.00%
  7. Back Pain: 3 people, 10.00%
  8. Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 3 people, 10.00%
  9. Constipation: 3 people, 10.00%
  10. Multiple Myeloma (cancer of the plasma cells): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan and Ramelteon?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Losartan and Ramelteon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Losartan interactions:

Browse all interactions between Losartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ramelteon interactions:

Browse all interactions between Ramelteon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium and ramelteon (the active ingredients of Losartan and Ramelteon, respectively), and Losartan and Ramelteon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Losartan and Ramelteon.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: